Cavalier E, Carlisi A, Chapelle JP, Delanaye P. False positive PTH results: an easy strategy to test and detect analytical interferences in routine practice. Clin Chim Acta 2008;387:150-2. (Pubitemid 350050930)
Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate- specifi c antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194:755-63.
Stenman UH, Paus E, Allard WJ, Andersson I, Andres C, Barnett TR, et al. Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specifi c antigen. Tumour Biol 1999;20(Suppl 1):1-12.
Kort SA, Martens F, Vanpoucke H, van Duijnhoven HL, Blankenstein MA. Comparison of 6 automated assays for total and free prostate-specifi c antigen with special reference to their reactivity toward the WHO 96/670 reference preparation. Clin Chem 2006;52:1568-74. (Pubitemid 44148320)
Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, et al. Prostate-specifi c antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991;37:1618-25. (Pubitemid 21905228)
Zisman A, Zisman E, Lindner A, Velikanov S, Siegel YI, Mozes E. Autoantibodies to prostate specifi c antigen in patients with benign prostatic hyperplasia. J Urol 1995;154:1052-5.
